Trials in Cincinnati, Ohio
Here are the top 10 medical studies for prostate cancer in Cincinnati, Ohio
Popular Filters
Phase 3 Trials
Checkpoint Inhibitor
Pembrolizumab + ADT for Prostate Cancer
Recruiting2 awardsPhase 3
Cincinnati, Ohio
This trial will test whether a combination of drugs is better than placebo at extending radiographic progression-free survival and overall survival for men with metastatic hormone-sensitive prostate cancer.
Radiation
Darolutamide + Standard Therapy for Prostate Cancer
Recruiting1 awardPhase 3
Kettering, Ohio
This trial is testing darolutamide, a new drug added to standard hormone therapy, in men with high-risk localized prostate cancer undergoing radiation. The goal is to see if this combination can better prevent the cancer from coming back and spreading compared to current treatments. Darolutamide works by blocking male hormones that help cancer grow, potentially reducing death rates from prostate cancer.
Radioisotope Therapy
Lu-177 PSMA Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Cincinnati, Ohio
This trial is testing a radioactive treatment in patients with advanced prostate cancer that hasn't responded to other treatments. The treatment targets and kills cancer cells using radiation and has shown promising outcomes, including reduced disease progression and improved overall survival.
Radiation
Apalutamide + Radiotherapy for Prostate Cancer
Recruiting2 awardsPhase 3
Cincinnati, Ohio
This trial is testing if adding a new medication to standard prostate cancer treatments can better delay the spread of cancer or death. The combination works by blocking male hormones, killing cancer cells, and lowering hormone levels.
Hormone Therapy
Hormone + Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Columbus, Ohio
This trial is testing two different intensities of hormone therapy and radiation therapy, comparing them to the current standard of care, in order to determine the best treatment plan for patients with high risk prostate cancer.
Trials With No Placebo
Monoclonal Antibodies
ONC-392 + Pembrolizumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Cincinnati, Ohio
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Radiopharmaceutical
Radium-223 + M3814 + Avelumab for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Lexington, Kentucky
This trial is testing a new drug, M3814, to see if it can help treat prostate cancer that has spread to other parts of the body and is no longer responsive to hormonal therapy. M3814 will be given alone or in combination with other drugs, and the goal is to see if it can lower the chances of the cancer growing or spreading.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.